Thapelo Maseko scored the winning goal as his new side, AEL Limassol, beat Mihlali Mayambela's new employers Omonia Nicosia 2-1 in the Cypriot Cup on Wednesday night. The 22-year-old speedy winger ...

ABSTRACT: Background: Propensity score methods have become a cornerstone of modern causal inference, enabling researchers to approximate the conditions of randomized experiments in observational ...

1 Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou, China. 2 School of International Education, Southern Medical University, Guangzhou, China. 3 Guangdong ...

Background: Type 2 diabetes (T2DM) and hypertension (HTN) are key risk factors for retinopathy and often coexist with coronary heart disease (CHD). While AI-based retinal imaging predicts CHD risk, ...

Sun, 30 Nov 2025 12:27:13 pm India vs South Africa 1st ODI Match Live Score: With Shubman Gill unavailable due to neck injury, Yashasvi Jaiswal is all set to open alongside Rohit Sharma. The young ...

Objective: Thymic tumors are a rare group of anterior mediastinal tumors. Surgery is the primary treatment. Adjuvant treatment is used in select cases. The purpose of this study was to evaluate the ...

Lionel Messi's night started with tears swelling in his eyes, fighting back tears during pregame warmups. He kept his emotions in check for the most part, while his three sons stood in front of him ...

Objective Patients with non-ST segment elevation acute coronary syndrome (NSTEACS) admitted into emergency department are usually combined with a high number of comorbidities. Charlson Comorbidity ...

A panelist discusses how a large propensity score–matched analysis of 1300 patients aged 60-75 found similar all-cause mortality between intensive chemotherapy and azacitidine plus venetoclax, but ...

As accountable care organizations’ (ACOs) maturity increased, hospitals participating in CMS ACOs were making progress toward enhanced performance but required more time to improve cost and quality ...

Background Head-to-head randomised trials or real-world studies comparing the safety and efficacy of natalizumab and anti-CD20 monoclonal antibodies are limited. This study aimed to compare the ...